IXICO (LSE:IXI) FCF Margin %: -45.78% (As of Mar. 2026)


What is IXICO FCF Margin %?

IXICO LSE:IXI FCF Margin % is -45.78% as of Mar. 2026. The stock has 2 warning signs investors should review. Among 959 Biotechnology companies, IXICO ranks better than 55.68% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. IXICO's Free Cash Flow for the six months ended in Mar. 2026 was £-1.81 Mil. IXICO's Revenue for the six months ended in Mar. 2026 was £3.95 Mil. Therefore, IXICO's FCF Margin % for the quarter that ended in Mar. 2026 was -45.78%.

As of today, IXICO's current FCF Yield % is -18.09%.

The historical rank and industry rank for IXICO's FCF Margin % or its related term are showing as below:

LSE:IXI' s FCF Margin % Range Over the Past 10 Years
Min: -47.71   Med: -16.84   Max: 8.13
Current: -44.76

During the past 13 years, the highest FCF Margin % of IXICO was 8.13%. The lowest was -47.71%. And the median was -16.84%.

LSE:IXI's FCF Margin % is ranked better than
55.68% of 959 companies
in the Biotechnology industry
Industry Median: -84.65 vs LSE:IXI: -44.76

IXICO FCF Margin % Related Terms

IXICO FCF Margin % Historical Data

* Premium members only.

The historical data trend for IXICO's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

IXICO FCF Margin % Chart

IXICO Annual Data
Trend Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
FCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -16.77 -9.50 -24.92 -38.21 -28.73

IXICO Semi-Annual Data
Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -58.55 -22.21 -13.37 -43.54 -45.78

LSE:IXI vs VRTX, REGN, ALNY: FCF Margin % Comparison

For the Biotechnology subindustry, IXICO's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

IXICO FCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, IXICO's FCF Margin % distribution charts can be found below:

* The bar in red indicates where IXICO's FCF Margin % falls into.


IXICO FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

IXICO's FCF Margin for the fiscal year that ended in Sep. 2025 is calculated as

FCF Margin=Free Cash Flow (A: Sep. 2025 )/Revenue (A: Sep. 2025 )
=-1.877/6.534
=-28.73 %

IXICO's FCF Margin for the quarter that ended in Mar. 2026 is calculated as

FCF Margin=Free Cash Flow (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=-1.808/3.949
=-45.78 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of -45.78% mean?
IXICO (LSE:IXI) has a FCF Margin % of -45.78% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on IXICO and its competitors. According to the industry distribution chart, IXICO ranks #425 out of 959 companies in the Biotechnology industry, placing it in the top 44.3%.
Is IXICO's FCF Margin % too high?
IXICO's current FCF Margin % is -45.78%. Based on the distribution chart, IXICO ranks #425 out of 959 companies in the Biotechnology industry, which is above the industry midpoint.
How does IXICO's FCF Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, IXICO ranks #425 out of 959 companies for FCF Margin %. This puts IXICO in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Biotechnology company?
A good FCF Margin % depends on the Biotechnology industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on IXICO and its competitors. IXICO's current FCF Margin % is -45.78%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is IXICO stock overvalued right now?
Based on GuruFocus' analysis, IXICO (LSE:IXI) is currently considered Fairly Valued. The stock's GF Value™ is £0.08, compared to a current price of £0.08 — trading 5.6% above its estimated fair value. The current FCF Margin % is -45.78%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For IXICO (LSE:IXI), the current FCF Margin % is -45.78% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

IXICO Business Description

Address 15 Long Lane, 4th Floor, Griffin Court, London, GBR, EC1A 9PN
IXICO PLC provides neuroscience imaging and biomarker analytics services, using its proprietary AI-driven platform to help advance the treatment of neurological disorders and reduce the uncertainties associated with drug discovery, development and monitoring. It operates as an imaging contract research organization, supporting clinical trials for neurological disorders by processing and analyzing imaging data. Its platform is used to measure biomarkers associated with diseases such as Alzheimer's, Huntington's, and Parkinson's.